Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations-Reference-Cited by-同舟云学术

Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations

Published:2019-01 Issue: Volume:7 Page:251513551982648
ISSN:2515-1355
Container-title:Therapeutic Advances in Vaccines and Immunotherapy
language:en
Short-container-title:Therapeutic Advances in Vaccines and Immunotherapy

Author:

Sullivan Sheena G.¹²^ORCID,Price Olivia H.³,Regan Annette K.⁴

Affiliation:

1. WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, Victoria 3000, Australia

2. School of Population and Global Health, University of Melbourne, Australia Fielding School of Public Health, University of California, Los Angeles, CA, USA

3. WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia

4. School of Public Health, Texas A&M University, College Station, TX, United States; School of Public Health, Curtin University, Perth, Western Australia, Australia, and Wesfamers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Crawley, Western Australia, Australia

Abstract

Vaccination is the most practical means available for preventing influenza. Influenza vaccines require frequent updates to keep pace with antigenic drift of the virus, and the effectiveness, and sometimes the safety, of the vaccine can therefore vary from season to season. Three key populations that the World Health Organization recommends should be prioritized for influenza vaccination are pregnant women, children younger than 5 years of age and the elderly. This review discusses the burden of influenza and the safety and effectiveness profile of influenza vaccines recommended for these groups.

Publisher

SAGE Publications

Link

http://journals.sagepub.com/doi/pdf/10.1177/2515135519826481

Reference172 articles.

1. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination

2. Economic evidence of influenza vaccination in children

3. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009–2010 Northern Hemisphere season

4. Large trials confirm immunogenicity of H1N1 vaccines

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lot-to-lot consistency, immunogenicity and safety of a quadrivalent split virion inactivated influenza vaccine in healthy population aged 9–59 years: A randomized, double-blind, controlled, phase IV clinical trial;Vaccine;2024-08

2. Effectiveness of influenza vaccine among the population in Chongqing, China, 2018–2022: A test negative design-based evaluation;Human Vaccines & Immunotherapeutics;2024-07-18

3. Broad-spectrum RNA antiviral inspired by ISG15^-/-deficiency;2024-06-28

4. Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine;npj Vaccines;2024-06-26

5. Acceptability, cost-effectiveness, and capacity of a facility-based seasonal influenza vaccination among high-risk groups: a study protocol in selected tertiary care hospitals of Bangladesh;BMC Public Health;2024-01-20